Richard P Baum

Richard P Baum

UNVERIFIED PROFILE

Are you Richard P Baum?   Register this Author

Register author
Richard P Baum

Richard P Baum

Publications by authors named "Richard P Baum"

Are you Richard P Baum?   Register this Author

100Publications

-Reads

Theranostics of prostate cancer: from molecular imaging to precision molecular radiotherapy targeting the prostate specific membrane antigen.

Br J Radiol 2018 Nov 1;91(1091):20180308. Epub 2018 Jun 1.

1 Theranostics Center for Molecular Radiotherapy and Molecular Imaging, Zentralklinik Bad Berka , Bad Berka , Germany.

View Article
November 2018

Pregnancy and Delivery After PRRT Without Sequelae.

Clin Nucl Med 2018 Nov;43(11):842-845

From the THERANOSTICS Center for Molecular Radiotherapy and Molecular Imaging, Zentralklinik Bad Berka, Bad Berka, Germany.

View Article
November 2018

Health-Related Quality of Life in Patients With Progressive Midgut Neuroendocrine Tumors Treated With Lu-Dotatate in the Phase III NETTER-1 Trial.

J Clin Oncol 2018 Sep 7;36(25):2578-2584. Epub 2018 Jun 7.

Jonathan Strosberg, Moffitt Cancer Center, Tampa, FL; Edward Wolin, Montefiore Einstein Center for Cancer Care, Bronx, NY; Beth Chasen, University of Texas MD Anderson Cancer Center, Houston, TX; Matthew Kulke, Dana-Farber Cancer Institute, Boston, MA; David Bushnell, University of Iowa, Iowa City, IA; Martyn Caplin, Royal Free Hospital, London, United Kingdom; Richard P. Baum, Zentralklinik, Bad Berka, Germany; Pamela Kunz, Stanford University Medical Center, Stanford; Andrew Hendifar, Cedars Sinai Medical Center, Los Angeles, CA; Timothy Hobday, Mayo Clinic College of Medicine, Rochester, MN; Kjell Oberg, University Hospital, Uppsala University, Uppsala, Sweden; Maribel Lopera Sierra, Thomas Thevenet, and Ines Margalet, Advanced Accelerator Applications, Geneva, Switzerland; Philippe Ruszniewski, Hopital Beaujon and Paris Diderot University, Clichy, France; and Eric Krenning, Erasmus Medical Center, Rotterdam, Netherlands.

View Article
September 2018

Ten-Year Survival After Peptide Receptor Radionuclide Therapy of a Metastatic Well-differentiated G3 Pancreatic Neuroendocrine Neoplasm.

Clin Nucl Med 2018 Sep;43(9):676-678

From the THERANOSTICS Center for Molecular Radiotherapy and Molecular Imaging, ENETS Center of Excellence, Zentralklinik Bad Berka, Bad Berka, Germany.

View Article
September 2018

Salivary Gland Toxicity of PSMA Radioligand Therapy: Relevance and Preventive Strategies.

J Nucl Med 2018 Aug 14;59(8):1172-1173. Epub 2018 Jun 14.

Theranostics Center for Molecular Radiotherapy and Molecular Imaging, Zentralklinik, Bad Berka, Germany; and.

View Article
August 2018

Peptide Receptor Radionuclide Therapy in Grade 3 Neuroendocrine Neoplasms: Safety and Survival Analysis in 69 Patients.

J Nucl Med 2018 Aug 16. Epub 2018 Aug 16.

THERANOSTICS Center for Molecular Radiotherapy & Molecular Imaging, Zentralklinik Bad Berka.

View Article
August 2018

PRRT genomic signature in blood for prediction of Lu-octreotate efficacy.

Eur J Nucl Med Mol Imaging 2018 07 26;45(7):1155-1169. Epub 2018 Feb 26.

LuGenIum Consortium, Milan, Rotterdam, London, Bad Berka, 54 Portland Place, London, W1B1DY, UK.

View Article
July 2018

Well-Founded Recommendations for Radioactive Iodine Treatment of Differentiated Thyroid Cancer Require Balanced Study of Benefits and Harms.

J Clin Oncol 2018 Jun 3;36(18):1887-1888. Epub 2018 May 3.

Mark Tulchinsky, Pennsylvania State University, Hershey, PA; Richard P. Baum, Theranostics Center for Molecular Radiotherapy and Molecular Imaging, Bad Berka, Germany; K.G. Bennet, American College of Nuclear Medicine, Downers Grove, IL; Leonard M. Freeman, Albert Einstein College of Medicine, Bronx, NY; Ian Jong, Monash Health, Melbourne, Victoria, Australia; Kalevi Kairemo, Docrates Cancer Center, Helsinki, Finland; Carol S. Marcus, David Geffen School of Medicine at University of California, Los Angles, Los Angeles, CA; Renee M. Moadel, Albert Einstein College of Medicine, Bronx, NY; and Paritosh Suman, Columbia University-Harlem Hospital Center, New York, NY.

View Article
June 2018

Results and adverse events of personalized peptide receptor radionuclide therapy with Yttrium and Lutetium in 1048 patients with neuroendocrine neoplasms.

Oncotarget 2018 Mar 15;9(24):16932-16950. Epub 2018 Feb 15.

Department of Gastroenterology/Endocrinology, Center for Neuroendocrine Tumors Bad Berka - ENETS Center of Excellence, Zentralklinik Bad Berka GmbH, Bad Berka, Germany.

View Article
March 2018

Injection of Botulinum Toxin for Preventing Salivary Gland Toxicity after PSMA Radioligand Therapy: an Empirical Proof of a Promising Concept.

Nucl Med Mol Imaging 2018 Feb 11;52(1):80-81. Epub 2018 Jan 11.

1Theranostics Center for Molecular Radiotherapy and Molecular Imaging, Zentralklinik Bad Berka, Bad Berka, Germany.

View Article
February 2018

Theranostics of Neuroendocrine Tumors.

Visc Med 2017 Oct 20;33(5):358-366. Epub 2017 Oct 20.

THERANOSTICS Center for Molecular Radiotherapy and Molecular Imaging, ENETS Center of Excellence, Zentralklinik Bad Berka, Bad Berka, Germany.

View Article
October 2017

Theranostic Prospects of Gastrin-Releasing Peptide Receptor-Radioantagonists in Oncology.

PET Clin 2017 Jul 3;12(3):297-309. Epub 2017 Apr 3.

Theranostics Center for Molecular Radiotherapy and Molecular Imaging, Zentralklinik Bad Berka, Bad Berka 99497, Germany.

View Article
July 2017

Morphological and Functional Imaging for Detecting and Assessing the Resectability of Neuroendocrine Liver Metastases.

Neuroendocrinology 2018 21;106(1):74-88. Epub 2017 Jul 21.

Department of Radiology, University Hospitals of Beaujon, Clichy, France.

View Article
July 2017

NTR Is the New SSTR? Perspective for Neurotensin Receptor 1 (NTR)-Directed Theranostics.

J Nucl Med 2017 Jun 9;58(6):934-935. Epub 2017 Mar 9.

Theranostics Center for Molecular Radiotherapy and Molecular Imaging, Zentralklinik, Bad Berka, Germany.

View Article
June 2017

First-in-Human PET/CT Imaging of Metastatic Neuroendocrine Neoplasms with Cyclotron-Produced Sc-DOTATOC: A Proof-of-Concept Study.

Cancer Biother Radiopharm 2017 May;32(4):124-132

1 Theranostics Center for Molecular Radiotherapy and Molecular Imaging, ENETS Center of Excellence , Zentralklinik Bad Berka, Germany .

View Article
May 2017

Novel Radiolabeled Bisphosphonates for PET Diagnosis and Endoradiotherapy of Bone Metastases.

Pharmaceuticals (Basel) 2017 May 18;10(2). Epub 2017 May 18.

Institute of Nuclear Chemistry, Johannes Gutenberg University Mainz, Fritz-Strassmann-Weg 2, 55128 Mainz, Germany.

View Article
May 2017

Rapid Synthesis of Ga-labeled macroaggregated human serum albumin (MAA) for routine application in perfusion imaging using PET/CT.

Appl Radiat Isot 2017 Apr 9;122:72-77. Epub 2017 Jan 9.

Department of Nuclear Medicine, University Hospital Halle(Saale), Germany.

View Article
April 2017

Imaging of Prostate Cancer Using Cu-Labeled Prostate-Specific Membrane Antigen Ligand.

PET Clin 2017 Apr 31;12(2):193-203. Epub 2017 Jan 31.

THERANOSTICS Center for Molecular Radiotherapy and Molecular Imaging (PET/CT), ENETS Center of Excellence, Zentralklinik Bad Berka, Robert-Koch-Allee 9, Bad Berka 99437, Germany.

View Article
April 2017

Prostate Cancer Imaging in the Era of Molecular Medicine.

PET Clin 2017 04;12(2):xi

Nuclear Medicine Unit, Building 30, AOU di Bologna, Policlinico S.Orsola-Malpighi, Via Massarenti 9, 40138 Bologna, Italy. Electronic address:

View Article
April 2017

Phase 3 Trial of Lu-Dotatate for Midgut Neuroendocrine Tumors.

N Engl J Med 2017 01;376(2):125-135

From the Moffitt Cancer Center, Tampa, FL (J.S., G.E.-H.); Markey Cancer Center, University of Kentucky, Lexington (E.W.); Cedars Sinai Medical Center, Los Angeles (A.H.), and Stanford University School of Medicine, Stanford (E.M., P.L.K.) - both in California; University of Texas M.D. Anderson Cancer Center (J.Y., B.C.) and Excel Diagnostics Imaging Clinic (E.D.), Houston; Dana-Farber Cancer Institute, Boston (M.H.K., H.J.); University of Iowa, Iowa City (D.B., T.M.O.); Zentralklinik, Bad Berka (R.P.B., H.R.K.), and Charité-Universitätsmedizin, Berlin (M.P.) - both in Germany; Royal Free Hospital (M.C.) and King's College Hospital NHS Foundation Trust (R.S.), London, and Beatson Oncology Centre, Glasgow (N.R.) - all in the United Kingdom; Hôpital Beaujon, Clichy (R.L., P.R.), and Advanced Accelerator Applications, St. Genis-Pouilly (T.T.) - both in France; Mayo Clinic College of Medicine, Rochester, MN (T.H.); University Hospitals and KU Leuven, Leuven, Belgium (E.V.C.); Robert H. Lurie Comprehensive Cancer Center, Chicago (A.B.); Hospital Universitari de Bellvitge, Barcelona (J.M.), and Hospital Universitario Ramón y Cajal, Madrid (E.G.) - both in Spain; Vanderbilt University Medical Center, Nashville (J.B.); Fondazione Istituto di Ricovero e Cura a Carattere Scientifico Istituto Nazionale dei Tumori, Milan (E.S.); University Hospital, Uppsala University, Uppsala, Sweden (K.O.); Advanced Accelerator Applications USA, New York (M.L.S., P.S., J.L.E.); and Erasmus Medical Center, Rotterdam, the Netherlands (D.K., E.K.).

View Article
January 2017

PSMA-Based Radioligand Therapy for Metastatic Castration-Resistant Prostate Cancer: The Bad Berka Experience Since 2013.

J Nucl Med 2016 Oct;57(Suppl 3):97S-104S

Theranostics Center for Molecular Radiotherapy and Molecular Imaging, Zentralklinik Bad Berka, Bad Berka, Germany

View Article
October 2016

Advances in the Diagnosis of Neuroendocrine Neoplasms.

Semin Nucl Med 2016 09;46(5):395-404

THERANOSTICS Center for Molecular Radiotherapy and Molecular Imaging, ENETS Center of Excellence, Zentralklinik Bad Berka, Bad Berka, Germany. Electronic address:

View Article
September 2016

Malignant presacral ghrelinoma with long-standing hyperghrelinaemia.

Ups J Med Sci 2015 20;120(4):299-304. Epub 2015 Jun 20.

e 5 Department of Pathology, County Hospital Ryhov , Jönköping, Sweden.

View Article
August 2016

Safety and Efficacy of 68Ga-DOTATATE PET/CT for Diagnosis, Staging, and Treatment Management of Neuroendocrine Tumors.

J Nucl Med 2016 05 14;57(5):708-14. Epub 2016 Jan 14.

Veterans Affairs Hospital, Tennessee Valley VA Healthcare System, Nashville, Tennessee Department of Radiology and Radiological Sciences, Vanderbilt University Medical Center, Nashville, Tennessee Vanderbilt-Ingram Cancer Center, Nashville, Tennessee; and

View Article
May 2016

Peptide Receptor Radionuclide Therapy (PRRT) of Medullary and Nonmedullary Thyroid Cancer Using Radiolabeled Somatostatin Analogues.

Semin Nucl Med 2016 May;46(3):215-24

THERANOSTICS Center for Molecular Radiotherapy and Molecular Imaging, ENETS Center of Excellence, Zentralklinik Bad Berka, Germany. Electronic address:

View Article
May 2016

Companion Diagnostics and Molecular Imaging.

Cancer J 2015 May-Jun;21(3):213-7

From the Theranostics Center for Molecular Radiotherapy and Molecular Imaging (PET/CT), ENETS Center of Excellence, Zentralklinik Bad Berka, Germany.

View Article
February 2016

Localization of Radiolabeled Somatostatin Analogs in the Spleen.

Clin Nucl Med 2016 Feb;41(2):e111-4

From the *Department of Nuclear Medicine, Erasmus MC, Rotterdam, the Netherlands; †Department of General and Visceral Surgery, and ‡Theranostics Center for Molecular Radiotherapy and Molecular Imaging, Zentralklinik Bad Berka, Bad Berka; §Institute of Pharmacology and Toxicology, Jena University Hospital, Jena; ∥Laboratory of Pathology and Cytology, Zentralklinik Bad Berka, Bad Berka, Germany; and ¶Department of Radiology, Erasmus MC, Rotterdam, the Netherlands.

View Article
February 2016

PET image segmentation using a Gaussian mixture model and Markov random fields.

EJNMMI Phys 2015 Dec 12;2(1). Epub 2015 Mar 12.

Institute of Telecommunications, Vienna University of Technology, Karlsplatz 13, Vienna, 1040 Wien, Austria.

View Article
December 2015

Peptide receptor radionuclide therapy with (90)Y/ (177)Lu-labelled peptides for inoperable head and neck paragangliomas (glomus tumours).

Eur J Nucl Med Mol Imaging 2015 Jul 31;42(8):1223-30. Epub 2015 Mar 31.

THERANOSTICS Centre for Molecular Radiotherapy and Molecular Imaging, ENETS Center of Excellence, Zentralklinik Bad Berka, Robert Koch Allee, Bad Berka, 99437, Germany.

View Article
July 2015

Analysis of somatostatin receptor 2A immunohistochemistry, RT-qPCR, and in vivo PET/CT data in patients with pancreatic neuroendocrine neoplasm.

Pancreas 2015 May;44(4):648-54

From the *Department of General and Visceral Surgery, Zentralklinik Bad Berka, Bad Berka; †STRATIFYER Molecular Pathology GmbH, Cologne; ‡Laboratory of Pathology and Cytology, Bad Berka; §Department of Nuclear Medicine, University Hospital Charité, Berlin; ∥Department of Pharmacology and Toxicology, Jena University Hospital, Friedrich Schiller University, Jena; and ¶Department of Molecular Radiotherapy and Molecular Imaging, Center for PET, Zentralklinik Bad Berka, Bad Berka, Germany.

View Article
May 2015

Third Theranostics World Congress on Gallium-68 and PRRT: Abstracts.

J Nucl Med 2015 May;56 Suppl 2:2A-30

Mallinckrodt Institute of Radiology Washington University St. Louis, St. Louis, MO.

View Article
May 2015

First-In-Human Study Demonstrating Tumor-Angiogenesis by PET/CT Imaging with (68)Ga-NODAGA-THERANOST, a High-Affinity Peptidomimetic for αvβ3 Integrin Receptor Targeting.

Cancer Biother Radiopharm 2015 May;30(4):152-9

1 THERANOSTICS Center for Molecular Radiotherapy and Molecular Imaging, Zentralklinik Bad Berka, ENETS Center of Excellence , Bad Berka, Germany .

View Article
May 2015

Development of a [177Lu]BPAMD labeling kit and an automated synthesis module for routine bone targeted endoradiotherapy.

Cancer Biother Radiopharm 2015 Mar 25;30(2):94-9. Epub 2015 Feb 25.

1 Institute of Nuclear Chemistry, Johannes Gutenberg University of Mainz , Mainz, Germany .

View Article
March 2015

Nuclear medicine innovations help (drive) healthcare (benefits).

Eur J Nucl Med Mol Imaging 2015 Feb;42(2):173-5

Division of Radiology and Nuclear Medicine, Department of Biomedical Imaging and Image-guided Therapy, Medical University of Vienna, Vienna, Austria.

View Article
February 2015

Long-term tolerability of PRRT in 807 patients with neuroendocrine tumours: the value and limitations of clinical factors.

Eur J Nucl Med Mol Imaging 2015 Jan 2;42(1):5-19. Epub 2014 Oct 2.

Division of Nuclear Medicine, European Institute of Oncology, via Ripamonti 435, 20141, Milan, Italy,

View Article
January 2015

The future of nuclear medicine imaging of neuroendocrine tumors: on a clear day one might see forever....

Eur J Nucl Med Mol Imaging 2014 Dec;41(12):2189-93

Division of Nuclear Medicine, European Institute of Oncology, Milan, Italy.

View Article
December 2014

PRRT: Defining the paradigm shift to achieve standardization and individualization.

J Nucl Med 2014 Nov 25;55(11):1753-6. Epub 2014 Sep 25.

Department of Gastroenterological Surgery, Yale University School of Medicine, New Haven, Connecticut; and.

View Article
November 2014

Gallium-68 DOTATOC PET/CT in vivo characterization of somatostatin receptor expression in the prostate.

Cancer Biother Radiopharm 2014 Apr 22;29(3):108-15. Epub 2014 Jan 22.

1 Faculty of Medicine, University of Belgrade , Serbia .

View Article
April 2014

Patient selection for personalized peptide receptor radionuclide therapy using Ga-68 somatostatin receptor PET/CT.

PET Clin 2014 Jan;9(1):83-90

THERANOSTICS Center for Molecular Radiotherapy and Molecular Imaging, ENETS Center of Excellence, Zentralklinik Bad Berka, Robert-Koch-Alle 9, 99437 Bad Berka, Germany.

View Article
January 2014

Theranostics with Ga-68 somatostatin receptor PET/CT: monitoring response to peptide receptor radionuclide therapy.

PET Clin 2014 Jan 19;9(1):91-7. Epub 2013 Oct 19.

THERANOSTICS Center for Molecular Radiotherapy and Molecular Imaging, ENETS Center of Excellence, Zentralklinik Bad Berka, 99437 Bad Berka, Germany.

View Article
January 2014

Relevance of PET for pretherapeutic prediction of doses in peptide receptor radionuclide therapy.

PET Clin 2014 Jan 5;9(1):99-112. Epub 2013 Oct 5.

Health & Environment Department, Biomedical Systems, AIT Austrian Institute of Technology, Donau-City-Strasse 1/2, Vienna A-1220, Austria.

View Article
January 2014

THERANOSTICS-clinical aimshots in surgical warfare against well-differentiated neuroendocrine neoplasms.

Ann Transl Med 2014 Jan;2(1)

1 Internal Medicine/Gastroenterology and Endocrinology, Center for Neuroendocrine Tumors Bad Berka-ENETS Center of Excellence, Zentralklinik Bad Berka GmbH, Robert-Koch-Allee 9, 99437 Bad Berka, Germany ; 2 THERANOSTICS Center for Molecular Radiotherapy and Molecular Imaging, Center for Neuroendocrine Tumors Bad Berka-ENETS Center of Excellence, Zentralklinik Bad Berka GmbH, Robert-Koch-Allee 9, 99437 Bad Berka, BRD, Germany.

View Article
January 2014

Successful treatment of metastasized pancreatic vasoactive intestinal polypeptide-secreting tumor unresponsive to high-dose octreotide by peptide receptor radionuclide therapy using 90Y DOTATATE.

Clin Nucl Med 2013 Dec;38(12):996-7

From the *Department of Nuclear Medicine, Hospital Clínico Universitario de Valladolid, Valladolid, Spain; and †THERANOSTICS Center for Molecular Radiotherapy and Molecular Imaging, ENETS Center of Excellence, Zentralklinik Bad Berka, Bad Berka, Germany.

View Article
December 2013

Peptide receptor radionuclide therapy of treatment-refractory metastatic thyroid cancer using (90)Yttrium and (177)Lutetium labeled somatostatin analogs: toxicity, response and survival analysis.

Am J Nucl Med Mol Imaging 2013 15;4(1):39-52. Epub 2013 Dec 15.

THERANOSTICS Center for Molecular Radiotherapy and Molecular Imaging, ENETS Center of Excellence Zentralklinik Bad Berka, Germany.

View Article
December 2013

Purification and labeling strategies for (68)Ga from (68)Ge/ (68)Ga generator eluate.

Recent Results Cancer Res 2013 ;194:77-87

Department of Nuclear Medicine, Centre for PETCT, Bad Berka, Germany.

View Article
June 2013

High uptake of (68)Ga-DOTATOC in spleen as compared to splenosis: measurement by PET/CT.

Recent Results Cancer Res 2013 ;194:373-8

Department of Nuclear Medicine, ENETS Center of Excellence, Zentralklinik Bad Berka, Bad Berka, Germany.

View Article
June 2013

Rare metastases detected by (68)Ga-somatostatin receptor PET/CT in patients with neuroendocrine tumors.

Recent Results Cancer Res 2013 ;194:379-84

Department of Nuclear Medicine, ENETS Center of Excellence, Zentralklinik Bad Berka, Bad Berka, Germany.

View Article
June 2013

Peptide receptor radionuclide therapy with (177)Lu labeled somatostatin analogs DOTATATE and DOTATOC: contrasting renal dosimetry in the same patient.

Recent Results Cancer Res 2013 ;194:551-9

Department of Nuclear Medicine and Center for PET/CT, ENETS Center of Excellence, Zentralklinik Bad Berka, Bad Berka, Germany.

View Article
June 2013

Is there a correlation between peptide receptor radionuclide therapy-associated hematological toxicity and spleen dose?

Recent Results Cancer Res 2013 ;194:561-6

Department of Nuclear Medicine/Center for PET/CT, ENETS Center of Excellence Zentralklinik Bad Berka, Bad Berka, Germany.

View Article
June 2013

A new automated NaCl based robust method for routine production of gallium-68 labeled peptides.

Appl Radiat Isot 2013 Jun 31;76:46-54. Epub 2012 Aug 31.

Department of Radiology, The University of Iowa, 200 Hawkins Drive, Iowa City, IA 52242, USA.

View Article
June 2013

Role of PET/CT in the functional imaging of endocrine pancreatic tumors.

Abdom Imaging 2012 Dec;37(6):1004-20

Department of Bioimaging and Radiological Sciences, Institute of Nuclear Medicine, Agostino Gemelli Hospital, Università Cattolica del Sacro Cuore, Roma, Italy.

View Article
December 2012

THERANOSTICS: From Molecular Imaging Using Ga-68 Labeled Tracers and PET/CT to Personalized Radionuclide Therapy - The Bad Berka Experience.

Theranostics 2012 7;2(5):437-47. Epub 2012 May 7.

Department of Nuclear Medicine/ Center for PET/CT, Zentralklinik Bad Berka, ENETS Center of Excellence, Zentralklinik Bad Berka, 99437 Bad Berka, Germany.

View Article
October 2012

Simplified NaCl based (68)Ga concentration and labeling procedure for rapid synthesis of (68)Ga radiopharmaceuticals in high radiochemical purity.

Bioconjug Chem 2012 Aug 19;23(8):1712-7. Epub 2012 Jul 19.

Zentralklinik Bad Berka, Department of Nuclear Medicine/PET Center, 99437 Bad Berka, Germany.

View Article
August 2012

Ga-68 Somatostatin Receptor PET/CT in von Hippel-Lindau Disease.

Nucl Med Mol Imaging 2012 Jun 27;46(2):129-33. Epub 2012 Apr 27.

Department of Nuclear Medicine and Center for PET/CT, Zentralklinik Bad Berka, 99437 Bad Berka, Germany.

View Article
June 2012

Peptides and receptors in image-guided therapy: theranostics for neuroendocrine neoplasms.

Semin Nucl Med 2012 May;42(3):190-207

Center for Molecular Radiotherapy and Molecular Imaging, ENETS Center of Excellence, Zentralklinik Bad Berka, Bad Berka, Germany.

View Article
May 2012

Intense 18F-fluoride accumulation in liver metastases from a neuroendocrine tumor after peptide receptor radionuclide therapy.

Clin Nucl Med 2012 Apr;37(4):e82-3

Department of Nuclear Medicine, PET Centre, Zentralklinik Bad Berka, Bad Berka, Germany.

View Article
April 2012

Radioguided surgery in neuroendocrine tumors using Ga-68-labeled somatostatin analogs: a pilot study.

Clin Nucl Med 2012 Feb;37(2):142-7

Department of General and Visceral Surgery, Zentralklinik Bad Berka, Bad Berka, Germany.

View Article
February 2012

Systemic Endoradiotherapy with Carrier-Added 4-[(131)I]Iodo-L-Phenylalanine: Clinical Proof-of-Principle in Refractory Glioma.

Nucl Med Mol Imaging 2011 Dec 16;45(4):299-307. Epub 2011 Nov 16.

Department of Nuclear Medicine, Experimental Nuclear Medicine and Radiopharmacy, University of Würzburg, 97080 Würzburg, Germany.

View Article
December 2011

Synthesis of O-(2-[18F]fluoroethyl)-L-tyrosine based on a cartridge purification method.

Nucl Med Biol 2011 Jul 30;38(5):653-8. Epub 2011 Mar 30.

Department of Nuclear Medicine/PET Center, Zentralklinik Bad Berka, 99437 Bad, Berka, Germany.

View Article
July 2011

Generator-based PET radiopharmaceuticals for molecular imaging of tumours: on the way to THERANOSTICS.

Dalton Trans 2011 Jun 29;40(23):6104-11. Epub 2011 Mar 29.

Institute of Nuclear Chemistry, Johannes Gutenberg University, Mainz, Germany.

View Article
June 2011

Standard imaging techniques for neuroendocrine tumors.

Endocrinol Metab Clin North Am 2011 Mar;40(1):153-62, ix

Division of Nuclear Medicine, Department of Radiology, University of Iowa Roy J. and Lucille A. Carver College of Medicine, 200 Hawkins Drive, Iowa City, IA 52242, USA.

View Article
March 2011

1 World Congress on Ga-68 and Peptide Receptor Radionuclide Therapy (PRRNT), June 23-26, 2011, Zentralklinik Bad Berka, Germany.

World J Nucl Med 2011 Jan;10(1):1-2

Prof. Richard Baum, Clinical Director, Zentralklinik Bad Berka, Germany E-mail:

View Article
January 2011

PET/CT imaging of osteoblastic bone metastases with (68)Ga-bisphosphonates: first human study.

Eur J Nucl Med Mol Imaging 2010 Apr 13;37(4):834. Epub 2010 Jan 13.

Institute of Nuclear Chemistry, Johannes Gutenberg University, Fritz-Strassmann-Weg 2, 55128 Mainz, Germany.

View Article
April 2010

FDG-PET/CT in lung cancer: an update.

Front Radiat Ther Oncol 2010 24;42:15-45. Epub 2009 Nov 24.

Department of Nuclear Medicine/Center for PET, Zentralklinik Bad Berka, Bad Berka, Germany.

View Article
March 2010

Detection of unknown primary neuroendocrine tumours (CUP-NET) using (68)Ga-DOTA-NOC receptor PET/CT.

Eur J Nucl Med Mol Imaging 2010 Jan;37(1):67-77

Department of Nuclear Medicine and Centre for PET/CT, Zentralklinik Bad Berka, Robert Koch Allee-9, 99437 Bad Berka, Germany.

View Article
January 2010

Interesting image. Pancreatic neuroendocrine tumor with involvement of the inferior mesenteric vein diagnosed by Ga-68 DOTA-TATE PET/CT.

Clin Nucl Med 2010 Jan;35(1):40-1

Department of Nuclear Medicine, Hospital Universitario Marqués de Valdecilla, Santander, Spain.

View Article
January 2010

Neoadjuvant peptide receptor radionuclide therapy for an inoperable neuroendocrine pancreatic tumor.

World J Gastroenterol 2009 Dec;15(46):5867-70

Department of General and Visceral Surgery, Zentralklinik Bad Berka, 99437 Bad Berka, Germany.

View Article
December 2009

Rhenium and 99m-technetium complexes of monosaccharide based tripodal triamines as potential radio imaging agents.

Dalton Trans 2009 Jul 13(26):5148-54. Epub 2009 May 13.

Laboratory of Organic and Macromolecular Chemistry, Friedrich-Schiller-University Jena, Humboldtstrasse 10, 07743 Jena, Germany.

View Article
July 2009

Multimodality image registration with software: state-of-the-art.

Eur J Nucl Med Mol Imaging 2009 Mar;36 Suppl 1:S44-55

AIM Program/Department of Imaging #A047, Cedars-Sinai Medical Center, 8700 Beverly Blvd, Los Angeles, CA 90048, USA.

View Article
March 2009

PET/CT in Neuroendocrine Tumors: Evaluation of Receptor Status and Metabolism.

PET Clin 2008 Jul 21;3(3):355-79. Epub 2009 Jun 21.

Department of Nuclear Medicine and Center for PET/CT, Zentralklinik Bad Berka GmbH, Robert Koch Allee-9, 99437 Bad Berka, Germany. Electronic address:

View Article
July 2008

Processing of generator-produced 68Ga for medical application.

J Nucl Med 2007 Oct 14;48(10):1741-8. Epub 2007 Sep 14.

Institute of Nuclear Chemistry, Johannes Gutenberg-Universität Mainz, Mainz, Germany.

View Article
October 2007